Trending Market News

Austria's Raiffeisen Bank will acquire Garanti BBVA's Romanian operations for €591 million ($680 million), marking its first major acquisition in recent years. The deal represents a strategic shift as Raiffeisen faces pressure to exit Russia following its invasion of Ukraine and Western sanctions. Upon completion in Q4, the acquisition will make Raiffeisen the third-largest bank in Romania by total assets.

• The transaction will have a negative 60 basis point impact on Raiffeisen's CET1 capital ratio, while BBVA expects a positive 10 basis point boost to its CET1 ratio and €112 million income statement benefit
• Raiffeisen plans to integrate the acquired business with its existing Romanian operations in what CEO Johann Strobl called 'one of the most attractive banking markets in Central and Eastern Europe'
• The deal marks a pivot for Raiffeisen toward core CEE markets amid ongoing pressure to withdraw from Russia due to geopolitical tensions and sanctions

Bank of America agreed to pay $72.5 million to settle a class action lawsuit brought by women who accused the bank of facilitating sexual abuse by Jeffrey Epstein. The settlement, which requires judicial approval, allows the bank to avoid trial despite denying it facilitated sex trafficking crimes. This follows similar settlements by JPMorgan Chase ($290 million) and Deutsche Bank ($75 million) with Epstein accusers.

• Judge Rakoff had ruled in January that Bank of America must face claims it knowingly benefited from Epstein's sex trafficking and obstructed federal trafficking victim protections
• The plaintiffs' attorneys may seek up to 30% of the settlement amount ($21.8 million) in legal fees, with a court hearing scheduled for Thursday to consider approval
• The lawsuit alleged BofA ignored suspicious financial transactions related to Epstein, including payments from Leon Black (Apollo Global Management co-founder) who paid Epstein $158 million for tax and estate planning services

Jeffrey Epstein victims filed a class action lawsuit against Google and the Trump administration in California federal court, alleging wrongful disclosure of personal information. The suit claims the Justice Department exposed about 100 survivors' identities in late 2025 and early 2026, and that Google's search engine and AI Mode feature continued republishing this information despite victims' requests for removal, causing renewed trauma and harassment.

• The lawsuit challenges Section 230 protections, arguing Google 'intentionally' fueled harassment through its AI Mode feature, which allegedly revealed victims' full names and personal details in response to queries
• The Justice Department released over 3 million pages of Epstein-related documents earlier this year after months of pressure, inadvertently 'outing' approximately 100 survivors
• The case follows recent lawsuits against Meta and YouTube over harmful content, with New Mexico's Attorney General suggesting these cases may prompt Congress to 'dramatically revise' Section 230 protections

Apple has hired Lilian Rincon, a former Google executive with nearly a decade of experience overseeing shopping and assistant products, as vice president of product marketing for artificial intelligence. The appointment comes as Apple prepares to launch an improved version of Siri this year, rebuilt using technology from Alphabet's Gemini AI model. Rincon will report directly to Apple's marketing chief Greg Joswiak.

• Rincon spent nearly 10 years at Google managing shopping and assistant products before joining Apple
• Apple is preparing to release an enhanced Siri virtual assistant in 2024, rebuilt with Alphabet's Gemini AI technology
• The new role reports to Greg 'Joz' Joswiak, Apple's marketing chief, signaling the strategic importance of AI marketing to the company

Flight attendants at Lufthansa and its regional airline Lufthansa Cityline have voted overwhelmingly to authorize strike action, with 94% support at Lufthansa and 99% at Cityline. The UFO union cited failed negotiations over a new labor agreement at Lufthansa and management's refusal to negotiate a social plan at Cityline, where operations affecting 800 cabin crew are being wound down.

• Strike authorization received near-unanimous support: 94% at Lufthansa and 99% at Cityline, with not a single 'no' vote cast at the regional carrier
• Cityline management refuses to negotiate a social plan despite plans to wind down operations affecting approximately 800 cabin crew members
• The union now has a mandate to escalate the labor dispute unless employers present meaningful proposals

Anthropic, the AI startup valued at $380 billion in its February 2026 funding round, is considering an initial public offering as early as Q4 2026. Bankers expect the IPO could raise more than $60 billion, though the company's plans remain fluid and could change. The move comes as Anthropic's annualized revenue has topped $19 billion, driven by strong enterprise AI and coding products.

• Anthropic's valuation surged from $183 billion in September 2025 to $380 billion in February 2026, when it raised $30 billion in Series G funding
• The company's annualized revenue exceeded $19 billion as of March 2026, more than double the $9 billion reported three months earlier, fueled by its Claude Code tool and AI models
• A federal judge issued a preliminary injunction blocking the government's ban on Anthropic's services for federal agencies, though the company faces potential billion-dollar losses from more than 100 customers expressing concerns

A U.S. appeals court overturned a $16.1 billion judgment against Argentina stemming from its 2012 seizure of 51% of state oil company YPF. The 2nd Circuit Court of Appeals questioned why the case was in U.S. courts given the underlying activity occurred in Argentina under Argentine law. This represents a significant victory for President Javier Milei's efforts to stabilize the country's struggling economy.

• The judgment would have represented 45% of Argentina's total 2024 budget and included $8.43 billion in damages plus $7.67 billion in prejudgment interest at 8%
• The case involved former YPF minority shareholders Petersen and Eton Park, who did not receive a tender offer when Argentina expropriated 51% of YPF for $5 billion in 2012
• UK-based litigation funder Burford Capital stood to collect much of any award, which had grown to $18 billion with interest by the time of appeal arguments

Eli Lilly announced that its eczema drug Ebglyss demonstrated durable effectiveness in a long-term post-marketing study, providing itch relief and skin clearance for up to four years in patients with moderate-to-severe atopic dermatitis. The once-monthly injectable treatment, approved in the U.S. in 2024, showed consistent safety with no new concerns identified. Lilly has submitted data to the FDA for a potential label update based on additional trial results.

• Majority of patients achieved near-complete skin clearance and itch relief with up to four years of continuous treatment with the once-monthly injection
• The drug is approved for adults and children 12 years and older with moderate-to-severe eczema who cannot use topical therapies
• Safety profile remained consistent with no new issues observed, and Lilly has submitted data to the FDA for a label update based on trials showing efficacy with dosing every four or eight weeks

Dutch technology investor Prosus is considering selling a roughly 10% stake in German food delivery company Delivery Hero to Aspex Management, according to Bloomberg. Prosus currently holds approximately 26.8% of Delivery Hero and is its largest shareholder, while Aspex is the second-largest shareholder. The potential sale comes amid tensions between Aspex and Delivery Hero's management.

• Preliminary discussions have already taken place between Prosus and Aspex regarding the potential stake sale
• The transaction would reduce Prosus's ownership in Delivery Hero from approximately 26.8% to around 16.8%
• Earlier this week, Aspex urged Delivery Hero's supervisory board to remove the CEO and top management team, signaling an activist push for strategic changes

Nestle is advancing the sale of a 50% stake in its water business, which includes Perrier and San Pellegrino brands, with a potential valuation of approximately 5 billion euros ($5.75 billion). Private equity firms CD&R, KKR, and PAI have progressed to the next round of bidding, with Platinum Equity also expressing interest in the deal.

• The stake sale could value Nestle's water business at about 5 billion euros ($5.75 billion)
• Three private equity firms—CD&R, KKR, and PAI—have advanced to the next bidding round for the 50% stake
• Platinum Equity has also expressed interest in acquiring part of the water business, according to sources familiar with the matter

Intercontinental Exchange, the parent company of the New York Stock Exchange, has invested $600 million in Polymarket, a prediction markets platform. The investment marks ICE's expansion into event-based trading, a segment that has rapidly grown from a niche crypto corner to a mainstream trading category in under two years.

• The $600 million investment is part of Polymarket's latest funding round, with final valuation to be disclosed once fundraising completes
• ICE stated the investment will not materially impact its financial results or capital return plans
• Prediction markets represent a new frontier in derivatives trading, potentially attracting more retail traders and helping exchanges diversify revenue as competition intensifies in traditional futures and options markets

Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy treating severe Leukocyte Adhesion Deficiency-I (LAD-I), a rare childhood disorder affecting white blood cells. This marks the first FDA-approved treatment for the disease, which kills 75% of untreated patients before age two. The company's shares rose following the announcement.

• Kresladi is a one-time gene therapy that collects a patient's blood stem cells, genetically corrects the faulty gene, and reinfuses them back into the patient
• The accelerated FDA approval was based on a trial showing 100% survival at 12 months post-infusion with no treatment-related serious side effects and sharply reduced serious infections
• Analysts view the approval as strategically important for de-risking Rocket's overall gene therapy platform, though Kresladi's commercial potential is limited and will likely see only a 'minimum viable launch strategy'

SoftBank Group has secured a $40 billion unsecured bridge loan to fund additional investments in OpenAI and general corporate purposes. The facility, arranged with major banks including JPMorgan Chase and Goldman Sachs, matures in March 2027. This comes after SoftBank previously committed $30 billion to OpenAI through its Vision Fund 2.

• The $40 billion bridge loan is unsecured and matures in March 2027, arranged by JPMorgan Chase, Goldman Sachs, Mizuho Bank, Sumitomo Mitsui Banking Corp, and MUFG Bank
• SoftBank had previously agreed to invest $30 billion in OpenAI through Vision Fund 2, making this loan part of an expanded investment strategy
• The facility will fund further investments in ChatGPT maker OpenAI as well as general corporate purposes for the Japanese investor

Volkswagen's software partnership with Rivian has reached a critical milestone with successful winter testing of vehicles using the jointly developed platform. The collaboration, central to CEO Oliver Blume's strategy to address VW's software struggles, brings Rivian closer to receiving the next payment from VW's $5.8 billion commitment through 2027. The partnership aims to help Volkswagen compete with Tesla and Chinese rivals like BYD.

• VW agreed to pay Rivian $5.8 billion by 2027, including a $1 billion tranche expected this year contingent on completing 'technological milestones'
• The joint venture will develop a software platform for VW's core brand, Scout pickup trucks, and Audi after years of problems at VW's own software unit Cariad
• Winter testing of the first vehicles using the new software platform has been successfully completed, marking progress toward the funding milestone

Japanese spacecraft startup ispace announced it will delay its NASA-sponsored lunar mission to 2030 (from 2027) and cut its global workforce following two failed lunar landing attempts. The company is shifting strategy to focus on launching five lunar orbiters by 2030 while consolidating moon lander development across its Japanese and U.S. units. The delay comes as NASA accelerates its Artemis program with plans for up to 30 uncrewed lunar missions starting next year.

• ispace will incur costs of several million dollars due to the strategic changes, leading to potential equity financing and a reduction of a few dozen staff members
• The company's third mission is scheduled for 2028 as part of Japan's lunar program, using an 'Ultra' lander capable of carrying 200 kg payloads
• Only two private companies, both U.S.-based (Intuitive Machines and Firefly Aerospace), have successfully landed on the Moon, while ispace remains the only private company outside the U.S. with moon landing technology

AstraZeneca announced on March 27 that its experimental drug tozorakimab successfully met primary endpoints in two late-stage clinical trials, demonstrating a meaningful reduction in exacerbations of chronic obstructive pulmonary disease (COPD), commonly known as 'smoker's lung'. The positive trial results represent a potential breakthrough in treating a major respiratory condition.

• Tozorakimab achieved its main goal in two separate late-stage trials for COPD treatment
• The drug showed meaningful reduction in disease flare-ups, which are critical events that worsen patient outcomes in COPD
• COPD, often called 'smoker's lung', is a chronic respiratory disease affecting millions globally, making this a significant market opportunity

Huawei's new 950PR AI chip has successfully completed customer testing and attracted orders from major Chinese tech companies ByteDance and Alibaba, marking a significant breakthrough for the company. The chip offers better compatibility with Nvidia's CUDA software system compared to Huawei's previous flagship chip, which struggled to gain adoption. Huawei plans to ship approximately 750,000 units in 2025, with mass production beginning next month.

• The 950PR chip is more compatible with Nvidia's CUDA software system and offers better response speeds, addressing adoption barriers that limited uptake of Huawei's previous Ascend 910C chip among major Chinese tech firms
• Huawei plans to ship around 750,000 950PR chips this year, with samples sent to customers in January and mass production starting in April, priced at 50,000 yuan ($6,900) for the standard version and 70,000 yuan for the premium HBM memory version
• The chip is designed to excel at AI inference workloads rather than raw computing power, aligning with China's shift from AI model development to real-world deployment as Nvidia faces ongoing U.S. export restrictions in the Chinese market

The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection Awiqli for treating type 2 diabetes in adults. The approval allows the Danish drugmaker to market the medication to help improve blood sugar control in this patient population.

• Awiqli is an insulin injection specifically approved for improving blood sugar levels in adults with type 2 diabetes
• The approval expands Novo Nordisk's diabetes treatment portfolio in the U.S. market
• The FDA clearance enables commercial distribution of the therapy to address the large type 2 diabetes patient population

A federal judge in San Francisco granted AI startup Anthropic a preliminary injunction against the Trump administration's decision to blacklist the company and ban federal agencies from using its Claude AI technology. The dispute arose after contract negotiations with the Pentagon fell apart over Anthropic's restrictions on using its AI for autonomous weapons and domestic mass surveillance. The judge questioned whether the government's actions constituted an 'attempt to cripple' the company.

• Anthropic is the first American company publicly designated a supply chain risk by the Defense Department, a label historically reserved for foreign adversaries, forcing Defense contractors like Palantir and Microsoft to certify they don't use Claude
• Contract talks broke down when the Pentagon demanded unfettered access to Anthropic's models for all lawful purposes, while Anthropic sought assurances its technology wouldn't be used for fully autonomous weapons or domestic mass surveillance
• Judge Rita Lin expressed concern that Anthropic is being 'punished' by the administration, noting that one amicus brief described the government's actions as 'attempted corporate murder'

OpenAI's advertising pilot program has surpassed $100 million in annualized revenue in less than two months since launching in the U.S. The ads appear at the bottom of ChatGPT responses for free and ChatGPT Go users, with the company now working with over 600 advertisers and planning expansion to Canada, Australia, and New Zealand.

• Roughly 85% of OpenAI's free and Go users in the U.S. are eligible to see ads, but less than 20% are shown them daily, reflecting a deliberately gradual rollout
• Ads are clearly labeled, do not influence ChatGPT responses, and are restricted from appearing near sensitive topics like politics, health, and mental health, with users under 18 excluded
• OpenAI reports no impact on privacy-related trust metrics and strong advertiser interest, though some advertisers have expressed frustration with the slow and conservative pace of the pilot expansion